Liminal FAILS to find partner for Ryplazim
Listen to the Q4 report around the 14 or 15 minute mark. They have been searching for a partner to develop Ryplazim, but have found NO ONE willing to put the money up to do this. Think about that before listening to NEWCAMO (Mr. Blah blah blah buy buy buy) They actually mention selling or shutting down Ryplazim, to save money as they only have enough left for 9 more months. Don't TRUST these thieves who charged the company $150M of FUTURE, repeat future, interest. That's right Thomvest extended the terms of a loan, due in sept 2019, out to fall of 2024. They then called the loan the following spring in April and demanded all FIVE YEARS of future interest at 19-20% interest rate. Then used that $150M to purchase shares at 1.5 cents each, reverse split became a $15 stock. Presently trading at $4 which is actually 0.4 cents... Not even half a cent. BEWARE NEW INVESTORS!!!!